Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation.
COVID-19
Cardiac arrest
Journal
European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263
Informations de publication
Date de publication:
14 03 2021
14 03 2021
Historique:
received:
08
09
2020
revised:
14
10
2020
accepted:
16
12
2020
pubmed:
6
2
2021
medline:
10
4
2021
entrez:
5
2
2021
Statut:
ppublish
Résumé
To study the characteristics and outcome among cardiac arrest cases with COVID-19 and differences between the pre-pandemic and the pandemic period in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA). We included all patients reported to the Swedish Registry for Cardiopulmonary Resuscitation from 1 January to 20 July 2020. We defined 16 March 2020 as the start of the pandemic. We assessed overall and 30-day mortality using Cox regression and logistic regression, respectively. We studied 1946 cases of OHCA and 1080 cases of IHCA during the entire period. During the pandemic, 88 (10.0%) of OHCAs and 72 (16.1%) of IHCAs had ongoing COVID-19. With regards to OHCA during the pandemic, the odds ratio for 30-day mortality in COVID-19-positive cases, compared with COVID-19-negative cases, was 3.40 [95% confidence interval (CI) 1.31-11.64]; the corresponding hazard ratio was 1.45 (95% CI 1.13-1.85). Adjusted 30-day survival was 4.7% for patients with COVID-19, 9.8% for patients without COVID-19, and 7.6% in the pre-pandemic period. With regards to IHCA during the pandemic, the odds ratio for COVID-19-positive cases, compared with COVID-19-negative cases, was 2.27 (95% CI 1.27-4.24); the corresponding hazard ratio was 1.48 (95% CI 1.09-2.01). Adjusted 30-day survival was 23.1% in COVID-19-positive cases, 39.5% in patients without COVID-19, and 36.4% in the pre-pandemic period. During the pandemic phase, COVID-19 was involved in at least 10% of all OHCAs and 16% of IHCAs, and, among COVID-19 cases, 30-day mortality was increased 3.4-fold in OHCA and 2.3-fold in IHCA.
Identifiants
pubmed: 33543259
pii: 6128749
doi: 10.1093/eurheartj/ehaa1067
pmc: PMC7928992
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1094-1106Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
N Engl J Med. 2010 Jul 29;363(5):434-42
pubmed: 20818864
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
BMC Bioinformatics. 2008 Jul 11;9:307
pubmed: 18620558
N Engl J Med. 2015 Jun 11;372(24):2307-15
pubmed: 26061835
Resuscitation. 2013 Jul;84(7):952-6
pubmed: 23313425
JAMA Cardiol. 2020 Oct 1;5(10):1154-1163
pubmed: 32558876
Heart. 2020 Dec;106(23):1812-1818
pubmed: 33023905
N Engl J Med. 2020 Jun 11;382(24):2368-2371
pubmed: 32302076
Lancet Public Health. 2020 Aug;5(8):e437-e443
pubmed: 32473113
Resuscitation. 2020 May;150:130-138
pubmed: 32209378
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1860-1865
pubmed: 32451271
Ann Epidemiol. 2006 Nov;16(11):834-41
pubmed: 16843678
Resuscitation. 2020 Aug;153:45-55
pubmed: 32525022
Resuscitation. 2005 Sep;66(3):271-83
pubmed: 16129543